OOIR: Observatory of International Research

Papers

(The H4-Index of Archives of Pharmacal Research is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Mouse models of nonalcoholic steatohepatitis and their application to new drug development	188
CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell–mediated cytotoxicity	144
Evaluation of bone health and fracture risk in type 2 diabetes: a network meta-analysis of anti-diabetic treatments versus placebo	73
Renal tubular PAR2 promotes interstitial fibrosis by increasing inflammatory responses and EMT process	72
Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation	71
Osteogenic effect of an adiponectin-derived short peptide that rebalances bone remodeling: a potential disease-modifying approach for postmenopausal osteoporosis therapy	58
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities	52
Correction to: The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer	51
Challenges and opportunities of developing small-molecule therapies for age-related macular degeneration	49
Impact of binge drinking on alcoholic liver disease	47
Retraction Note: Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats	46
Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway	45
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin	40
Regulation of NOX/p38 MAPK/PPARα pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight	39
Prenylated flavonoid fractions from Glycyrrhiza glabra alleviate insulin resistance in HepG2 cells by regulating the ERK/IRS-1 and PI3K/Akt signaling pathways	38
Advances in plant-derived natural products for antitumor immunotherapy	36
Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions	35
Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis	35
The role and application of transcriptional repressors in cancer treatment	34
Minor structural changes, major functional impacts: posttranslational modifications and drug targets	33
Non-alcoholic fatty liver disease and liver secretome	31
Recent advances on Pestalotiopsis genus: chemistry, biological activities, structure–activity relationship, and biosynthesis	31
Isolation, structure elucidation, total synthesis, and biosynthesis of dermazolium A, an antibacterial imidazolium metabolite of a vaginal bacterium Dermabacter vaginalis	31
Naringin promotes fat browning mediated by UCP1 activation via the AMPK signaling pathway in 3T3-L1 adipocytes	30
Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes	30

A review on bacteria-derived antioxidant metabolites: their production, purification, characterization, potential applications, and limitations	30
Anti-angiogenesis revisited: reshaping the treatment landscape of advanced non-small cell lung cancer	28
Tumor microenvironment regulation by reactive oxygen species-mediated inflammasome activation	28
Ginsenoside Rh1 inhibits tumor growth in MDA-MB-231 breast cancer cells via mitochondrial ROS and ER stress-mediated signaling pathway	28